Dr. Binusha Moitheennazima, MD

Dr. Moitheennazima practices at Nacogdoches Pulmonary and Sleep Associates PA in Nacogdoches, Texas.

Dr. Moitheennazima's NPI, 1760658330, was assigned on May 5, 2008. Dr. Moitheennazima graduated from University of Kerala Medical College in 2000. Dr. Moitheennazima holds Texas license N5256.

Dr. Moitheennazima's primary practice is Nacogdoches Pulmonary and Sleep Associates PA, at 1209 N Mound St, Nacogdoches, TX 75961 in Nacogdoches County. The practice phone is (938) 585-4646.

Dr. Moitheennazima's primary practice is Nacogdoches Pulmonary and Sleep Associates PA in Nacogdoches, Texas. Dr. Moitheennazima is also affiliated with Nacogdoches Medical Center. The medical group on file is Nacogdoches Pulmonary and Sleep Associates PA. Dmand AI also links Dr. Moitheennazima to 4 more hospitals, 1 group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moitheennazima practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Moitheennazima's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Moitheennazima is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Moitheennazima's licenses on file in 2 states: Texas and Connecticut.

Dmand AI lists acute sinusitis, asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pneumonia, pulmonary fibrosis and sleep apnea among the conditions Dr. Moitheennazima treats.

CMS data shows 13,402 Medicare services from Dr. Moitheennazima across 26 procedure codes in 2024, for 878 Medicare patients. Medicare paid $621,890 for them.

CMS counts 878 Medicare patients who saw Dr. Moitheennazima in 2024. The largest group is 65 to 74, with 381 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moitheennazima's median patient age at 64, with 53% women.

In 2024, Dr. Moitheennazima wrote 18,098 Medicare Part D claims for 1,217 patients. 77% of them were for generic drugs. CMS names the drug for 17,476 of them, across 185 drugs with 11 or more claims each, at $2,436,772 in total drug cost. In 2023, CMS named 15,654 claims across 175 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Moitheennazima for performance year 2024, reported as part of a group. Dr. Moitheennazima accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moitheennazima as offering telehealth.

Dmand AI links 2 papers to Dr. Moitheennazima in 2010. The most frequent topics are Continuous Positive Airway Pressure, Polysomnography and Sleep Apnea, Obstructive. Dr. Moitheennazima's most frequent co-author is Sachin Relia, MD.

CMS Open Payments shows 679 general payments to Dr. Moitheennazima from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. AstraZeneca Pharmaceuticals LP paid the most, $8,393.

Dmand AI lists 1 award for Dr. Moitheennazima, most recently CMS Stage 1 EHR in 2013.

Dr. Moitheennazima graduated from University of Kerala Medical College in 2000.

Dr. Moitheennazima is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.